Preferential promotion of White men within academic medicine is persisting, with racially and ethnically diverse women experiencing greater underpromotion.
(HealthDay News) — Nearly half of participants in a weight loss program who initiated an antiobesity medication and who consumed alcohol at baseline reported decreases in their alcohol use, according ...
Higher MTX-PG concentrations were associated with improved disease activity among patients with RA receiving MTX therapy, though they were also linked to hepatotoxicity.
Overall, 13.9 percent of adults age 65 years and older met the federal physical activity guidelines for both aerobic and muscle-strengthening activities in 2022.
Eptinezumab vs placebo significantly reduces acute headache medication in patients with migraine and those with medication overuse.
HealthDay News — For low-risk pregnancies, planned home births are as safe as planned birth center births, according to a study published in the December issue of Medical Care.
The coexistence of moderate-to-intense pain and depressive symptoms is a risk factor for the decline of global cognition and memory.
Native American vs non-Hispanic White adults have higher rates of chronic pain, with psychosocial factors, such as stress, as a mediator for pain inequity.
Yesintek, formerly known as Bmab 1200, is a human interleukin-12 and -23 antagonist. The FDA has approved Yesintek (Ustekinumab-kfce), a biosimilar to Stelara (Ustekinumab), for the treatment of ...
The risk for recurrent cardiovascular events is high among patients with r-axSpA and a history of these events, though TNF inhibitor therapy may offer protective benefits.
GLP-1 receptor agonist use is associated with benefits in a number of different disease and may help treat patients with lupus nephritis.
Using urate-lowering therapy to reach target urate levels appears safe in patients with chronic kidney disease (CKD).